Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11905535 Genetic engineering of fungi to modulate tryptamine expression

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
July 15, 2022
0
Date of Patent
February 20, 2024
0
Patent Applicant
‌
Empyrean Neuroscience
0
Patent Application Number
17812826
0
Patent Citations
‌
US Patent 10085995 Topical compositions and methods of treatment of anorectal disorders
0
‌
US Patent 10183001 Opioid and attention deficit hyperactivity disorder medications possessing abuse deterrent and anti-dose dumping safety features
0
‌
US Patent 10457667 Indolin-2-one derivatives
0
‌
US Patent 10519175 Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
0
‌
US Patent 10596378 Method for treatment of depression using synaptic pathway training
0
‌
US Patent 10729706 Psilocybin and/or psilocin in combination with cannabinoids and/or terpenes
0
‌
US Patent 10881606 Composition for transdermal delivery of cationic active agents
0
‌
US Patent 10881607 Composition for transdermal delivery of cationic active agents
0
‌
US Patent 10933073 Compositions and methods comprising a psilocybin derivative
0
‌
US Patent 10947257 Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
0
•••
Patent Inventor Names
Thomas Henley
0
Jose Fernandez-Gomez
0
Modassir Choudhry
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11905535
0
Patent Primary Examiner
‌
Suzanne M Noakes
0

Find more entities like US Patent 11905535 Genetic engineering of fungi to modulate tryptamine expression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo